Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Dybul

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|April 26, 2019
Can Changes in Service Delivery Models Improve Program Quality and Efficiency? A Closer Look at HIV Programs in Kenya and UgandaStephanie Kandasami, Hezekiah Shobiye, Ade Fakoya, et al.
Antiviral Therapy|May 12, 2009
Evolution of drug resistance after virological failure of a first-line highly active antiretroviral therapy regimen in UgandaSteven J Reynolds, Cissy Kityo, Frank Mbamanya, et al.
Annals of Internal Medicine|July 20, 2011
Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from UgandaEdward J Mills, Celestin Bakanda, Josephine Birungi, et al.
BMJ (Clinical Research Ed.)|November 29, 2021
Vaccines, therapeutics, and diagnostics for covid-19: redesigning systems to improve pandemic responseRohit Ramchandani, Michel Kazatchkine, Joanne Liu, et al.
AIDS (London, England)|September 6, 2012
Male sex and the risk of mortality among individuals enrolled in antiretroviral therapy programs in Africa: a systematic review and meta-analysisEric Druyts, Mark Dybul, Steve Kanters, et al.
Lancet (London, England)|January 15, 2023
Stopping epidemics when and where they occurEls Torreele, Michel Kazatchkine, Joanne Liu, et al.
Plos Medicine|August 17, 2016
Building from the HIV Response toward Universal Health CoverageJonathan Jay, Kent Buse, Marielle Hart, et al.
Virus Evolution|August 5, 2017
Phylodynamic analysis to inform prevention efforts in mixed HIV epidemicsErik M Volz, Nicaise Ndembi, Rebecca Nowak, et al.
JAMA|July 20, 2010
Use of generic antiretroviral agents and cost savings in PEPFAR treatment programsCharles B Holmes, William Coggin, David Jamieson, et al.
Lancet (London, England)|June 23, 2009
An assessment of interactions between global health initiatives and country health systems, Badara Samb, Tim Evans, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Journal of Acquired Immune Deficiency Syndromes (1999)|April 26, 2019
Can Changes in Service Delivery Models Improve Program Quality and Efficiency? A Closer Look at HIV Programs in Kenya and UgandaStephanie Kandasami, Hezekiah Shobiye, Ade Fakoya, et al.
Antiviral Therapy|May 12, 2009
Evolution of drug resistance after virological failure of a first-line highly active antiretroviral therapy regimen in UgandaSteven J Reynolds, Cissy Kityo, Frank Mbamanya, et al.
Annals of Internal Medicine|July 20, 2011
Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from UgandaEdward J Mills, Celestin Bakanda, Josephine Birungi, et al.
BMJ (Clinical Research Ed.)|November 29, 2021
Vaccines, therapeutics, and diagnostics for covid-19: redesigning systems to improve pandemic responseRohit Ramchandani, Michel Kazatchkine, Joanne Liu, et al.
AIDS (London, England)|September 6, 2012
Male sex and the risk of mortality among individuals enrolled in antiretroviral therapy programs in Africa: a systematic review and meta-analysisEric Druyts, Mark Dybul, Steve Kanters, et al.
Lancet (London, England)|January 15, 2023
Stopping epidemics when and where they occurEls Torreele, Michel Kazatchkine, Joanne Liu, et al.
Plos Medicine|August 17, 2016
Building from the HIV Response toward Universal Health CoverageJonathan Jay, Kent Buse, Marielle Hart, et al.
Virus Evolution|August 5, 2017
Phylodynamic analysis to inform prevention efforts in mixed HIV epidemicsErik M Volz, Nicaise Ndembi, Rebecca Nowak, et al.
JAMA|July 20, 2010
Use of generic antiretroviral agents and cost savings in PEPFAR treatment programsCharles B Holmes, William Coggin, David Jamieson, et al.
Lancet (London, England)|June 23, 2009
An assessment of interactions between global health initiatives and country health systems, Badara Samb, Tim Evans, et al.
Pageof 7